Education
About Us
Working with TipRanks
Follow Us
Enzon Pharmaceuticals (ENZN)
OTHER OTC:ENZN
Total Valuation
Enzon Pharmaceuticals has a market cap or net worth of $4.82M. The enterprise value is -$37.75M.
Market Cap$4.82M
Enterprise Value-$37.75M
Share Statistics
Enzon Pharmaceuticals has 74,214,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding74,214,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Enzon Pharmaceuticals’s return on equity (ROE) is 1.35 and return on invested capital (ROIC) is -3.22%.
Return on Equity (ROE)1.35
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-3.22%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Enzon Pharmaceuticals is ―. Enzon Pharmaceuticals’s PEG ratio is -0.00081.
PE Ratio―
PS Ratio0.00
PB Ratio-1.11
Price to Fair Value-1.11
Price to FCF-0.93
Price to Operating Cash Flow-1.60
PEG Ratio-0.00081
Income Statement
In the last 12 months, Enzon Pharmaceuticals had revenue of 0.00 and earned -3.41M in profits. Earnings per share was -0.07.
Revenue0.00
Gross Profit0.00
Operating Income-1.36M
Pretax Income-3.39M
Net Income-3.41M
EBITDA-1.36M
Earnings Per Share (EPS)-0.07
Cash Flow
In the last 12 months, operating cash flow was -3.01M and capital expenditures 0.00, giving a free cash flow of -3.01M billion.
Operating Cash Flow-3.01M
Free Cash Flow-3.01M
Free Cash Flow per Share-0.04
Dividends & Yields
Enzon Pharmaceuticals pays an annual dividend of $0.12, resulting in a dividend yield of ―
Dividend Per Share$0.12
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change-35.00%
50-Day Moving Average0.06
200-Day Moving Average0.07
Relative Strength Index (RSI)50.09
Average Volume (3m)23.36K
Important Dates
Enzon Pharmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Enzon Pharmaceuticals as a current ratio of 58.57, with Debt / Equity ratio of 0.00%
Current Ratio58.57
Quick Ratio58.57
Debt to Market Cap0.00
Net Debt to EBITDA31.40
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Enzon Pharmaceuticals has paid 19.00K in taxes.
Income Tax19.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Enzon Pharmaceuticals EV to EBITDA ratio is 29.32, with an EV/FCF ratio of 13.21.
EV to Sales0.00
EV to EBITDA29.32
EV to Free Cash Flow13.21
EV to Operating Cash Flow13.21
Balance Sheet
Enzon Pharmaceuticals has $42.57M in cash and marketable securities with $0.00 in debt, giving a net cash position of $42.57M billion.
Cash & Marketable Securities$42.57M
Total Debt$0.00
Net Cash$42.57M
Net Cash Per Share$0.57
Tangible Book Value Per Share-$0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Enzon Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―